stockgist
HomeTop MoversCompaniesConcepts

Market

  • Top Movers
  • Companies
  • Concepts

SEC Filings

  • AI Filing Analysis
  • Financial Reports
  • Current Reports
  • IPO Filings

Ownership

  • Institutional Holdings
  • Insider Trading

About

  • Data updates every 5 min
  • SEC EDGAR Source
© 2025–2026 StockGist|Information only, not investment advice
    1. Companies
    2. ISCO
    stockgist
    HomeTop MoversCompaniesConcepts
    ISCO logo

    International Stem Cell Corporation

    ISCO
    OTC
    Healthcare
    Biotechnology
    San Diego, CA, US32 employeesinternationalstemcell.com
    —

    At a Glance

    AI-generated

    Revenue grew modestly 16.5% to $9.1M as biomedical product sales gains offset anti-aging skincare weakness, but gross profit declined 4.8% to $5.1M due to higher production costs, widening operating and net losses amid ongoing cash management efforts.

    Revenue breakdown: Biomedical Market (96%), Anti Aging Skincare Market (2%), Anti Aging Market (2%).

    —

    Market Cap

    —

    Revenue

    —

    Net Income

    Employees32
    Fundamentals

    How The Business Makes Money

    Revenue by Segment

    Biomedical Market96%($67M)
    Anti Aging Skincare Market2%($1M)
    Anti Aging Market2%($1M)

    Revenue by Geography

    US85%($44M)
    Non Us9.9%($5M)
    Asia3.1%($2M)
    Europe1.7%($855.0K)
    Other Regions0.3%($156.0K)
    Activity

    What Changed Recently

    No significant events in the past 90 days.

    Peer Companies

    CompanyPriceChangeMarket CapP/E
    NSTMNovelStem International C...————
    UNBXUNBX————
    BMNDFBiomind Labs Inc.————
    VCNXVaccinex, Inc.————
    MRZMMarizyme, Inc.————
    BIORBiora Therapeutics, Inc.————
    CAIHFChia Tai Enterprises Inte...————
    EVFMEvofem Biosciences, Inc.————
    Analyst View
    Company Profile
    CIK0001355790
    ISINUS4603782016
    CUSIP460378102
    Phone760 940 6383
    Address9745 Businesspark Avenue, San Diego, CA, 92131, US
    SEC EDGAR

    Market

    • Top Movers
    • Companies
    • Concepts

    SEC Filings

    • AI Filing Analysis
    • Financial Reports
    • Current Reports
    • IPO Filings

    Ownership

    • Institutional Holdings
    • Insider Trading

    About

    • Data updates every 5 min
    • SEC EDGAR Source
    © 2025–2026 StockGist|Information only, not investment advice